New aspects antimicrobial resistance therapeutic dilemmas Emergence resistance antimicrobial agents susceptible organisms important obstacle successful treatment bacterial infections hospitals plasmid-mediated resistance third-generation cephalosporins monobactams gram-negative bacilli due mutations TEM- SHV-type enzymes nosocomial enterococci vancomycin resistance beta-lactamase production high-level resistance aminoglycosides organism formidable armamentarium resistance properties resistance fluoroquinolones rifampin methicillin-resistant Staphylococcus aureus community organisms resistance important role Haemophilus influenzae gonococci pneumococci countries beta-lactamase-producing meningococci first time selective pressure use antimicrobial agents ability bacteria resistance capacity humans bacteria antimicrobial resistance problem foreseeable future 